Novalis LifeSciences Investments II L.P. 13D and 13G filings for Telesis Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-06 4:05 pm Purchase | 2024-11-04 | 13D | Telesis Bio, Inc. TBIO | Novalis LifeSciences Investments II L.P. | 442,959 19.990% | 22,524 (+5.36%) | Filing |
| 2024-07-18 5:32 pm Unchanged | 2024-07-16 | 13D | Telesis Bio, Inc. TBIO | Novalis LifeSciences Investments II L.P. | 420,435 19.990% | 0 (Unchanged) | Filing |
| 2024-06-10 8:30 pm Purchase | 2024-06-06 | 13D | Telesis Bio, Inc. TBIO | Novalis LifeSciences Investments II L.P. | 420,435 19.990% | 8,214 (+1.99%) | Filing |
| 2023-06-15 4:17 pm Purchase | 2023-06-05 | 13D | Telesis Bio, Inc. TBIO | Novalis LifeSciences Investments II L.P. | 412,221 19.990% | 412,221 (New Position) | Filing |